Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Yamazaki

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
International Journal of Oncology|June 14, 2002
Ribozyme mediated suppression of vascular endothelial growth factor gene expression enhances matrix metalloproteinase 1 expression in a human hepatocellular carcinoma cell lineJunichiro Kamochi, Tetsuji Tokunaga, Fumitoshi Morino, et al.
International Journal of Oncology|October 9, 2003
The modifier subunit of glutamate cysteine ligase (GCLM) is a molecular target for amelioration of cisplatin resistance in lung cancerYoshimasa Inoue, Masashi Tomisawa, Hitoshi Yamazaki, et al.
Journal of Medicinal Chemistry|August 22, 2012
Identification, synthesis, and biological evaluation of 6-[(6R)-2-(4-fluorophenyl)-6-(hydroxymethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3(2H)-one (AS1940477), a potent p38 MAP kinase inhibitorToru Asano, Hitoshi Yamazaki, Chiyoshi Kasahara, et al.
Anticancer Research|November 10, 2019
Expression of Kita-Kyushu Lung Cancer Antigen-1 as Detected by a Novel Monoclonal Antibody in Gastric CancerYoshihito Takahashi, Takashi Fukuyama, Nobue Futawatari, et al.
International Journal of Oncology|July 16, 2004
The subunits of glutamate cysteine ligase enhance cisplatin resistance in human non-small cell lung cancer xenografts in vivoSakashi Fujimori, Yoshiyuki Abe, Masatake Nishi, et al.
International Journal of Oncology|March 13, 2003
Reversal of drug resistance mediated by hammerhead ribozyme against multidrug resistance-associated protein 1 in a human glioma cell lineHideo Osada, Tetsuji Tokunaga, Yoshiyuki Abe, et al.
International Journal of Oncology|October 9, 2002
Reversal of drug resistance using hammerhead ribozymes against multidrug resistance-associated protein and multidrug resistance 1 geneJunko Nagata, Hiroshi Kijima, Hiroyuki Hatanaka, et al.
International Journal of Oncology|March 9, 2005
Aberrant expression of the gastric mucin MUC6 in human pulmonary adenocarcinoma xenograftsAtsushi Hamamoto, Yoshiyuki Abe, Masatake Nishi, et al.
International Journal of Oncology|December 17, 2008
Thrombospondin 2 inhibits metastasis of human malignant melanoma through microenvironment-modification in NOD/SCID/gammaCnull (NOG) miceTsuyoshi Chijiwa, Yoshiyuki Abe, Norihiro Ikoma, et al.
Scientific Reports|April 19, 2018
Expression of KK-LC-1, a cancer/testis antigen, at non-tumour sites of the stomach carrying a tumourTakashi Fukuyama, Nobue Futawatari, Rui Yamamura, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
International Journal of Oncology|June 14, 2002
Ribozyme mediated suppression of vascular endothelial growth factor gene expression enhances matrix metalloproteinase 1 expression in a human hepatocellular carcinoma cell lineJunichiro Kamochi, Tetsuji Tokunaga, Fumitoshi Morino, et al.
International Journal of Oncology|October 9, 2003
The modifier subunit of glutamate cysteine ligase (GCLM) is a molecular target for amelioration of cisplatin resistance in lung cancerYoshimasa Inoue, Masashi Tomisawa, Hitoshi Yamazaki, et al.
Journal of Medicinal Chemistry|August 22, 2012
Identification, synthesis, and biological evaluation of 6-[(6R)-2-(4-fluorophenyl)-6-(hydroxymethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3(2H)-one (AS1940477), a potent p38 MAP kinase inhibitorToru Asano, Hitoshi Yamazaki, Chiyoshi Kasahara, et al.
Anticancer Research|November 10, 2019
Expression of Kita-Kyushu Lung Cancer Antigen-1 as Detected by a Novel Monoclonal Antibody in Gastric CancerYoshihito Takahashi, Takashi Fukuyama, Nobue Futawatari, et al.
International Journal of Oncology|July 16, 2004
The subunits of glutamate cysteine ligase enhance cisplatin resistance in human non-small cell lung cancer xenografts in vivoSakashi Fujimori, Yoshiyuki Abe, Masatake Nishi, et al.
International Journal of Oncology|March 13, 2003
Reversal of drug resistance mediated by hammerhead ribozyme against multidrug resistance-associated protein 1 in a human glioma cell lineHideo Osada, Tetsuji Tokunaga, Yoshiyuki Abe, et al.
International Journal of Oncology|October 9, 2002
Reversal of drug resistance using hammerhead ribozymes against multidrug resistance-associated protein and multidrug resistance 1 geneJunko Nagata, Hiroshi Kijima, Hiroyuki Hatanaka, et al.
International Journal of Oncology|March 9, 2005
Aberrant expression of the gastric mucin MUC6 in human pulmonary adenocarcinoma xenograftsAtsushi Hamamoto, Yoshiyuki Abe, Masatake Nishi, et al.
International Journal of Oncology|December 17, 2008
Thrombospondin 2 inhibits metastasis of human malignant melanoma through microenvironment-modification in NOD/SCID/gammaCnull (NOG) miceTsuyoshi Chijiwa, Yoshiyuki Abe, Norihiro Ikoma, et al.
Scientific Reports|April 19, 2018
Expression of KK-LC-1, a cancer/testis antigen, at non-tumour sites of the stomach carrying a tumourTakashi Fukuyama, Nobue Futawatari, Rui Yamamura, et al.
Pageof 10